Lillian Barra1, Renée L Borchin2, Cristina Burroughs2, George C Casey3, Carol A McAlear4, Antoine G Sreih4, Kalen Young3, Peter A Merkel5, Christian Pagnoux6. 1. Division of Rheumatology, Western University, London, Ontario, Canada. 2. Health Informatics Institute, University of South Florida, Tampa, FL, USA. 3. Vasculitis Foundation, Kansas City, MO, USA. 4. Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA. 5. Vasculitis Center, Division of Rheumatology; and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA. 6. Vasculitis clinic, Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Ontario, Canada. cpagnoux@mtsinai.on.ca.
Abstract
OBJECTIVES: Work disability associated with rheumatic diseases accounts for a substantial financial burden. However, few studies have investigated disability among patients with vasculitis. The purpose of this study was to examine the impact of vasculitis on patient employment and income. METHODS: Patients enrolled in the Vasculitis Clinical Research Consortium (VCRC) Patient Contact Registry, living in the USA or Canada, and followed for >1 year post-diagnosis, participated in an online survey-based study. RESULTS: 421 patients with different systemic vasculitides completed the survey between June and December 2015. The majority of patients were female (70%) and Caucasian (90%); granulomatosis with polyangiitis (GPA) was the most common type of vasculitis (49%), and the mean age at the time of diagnosis was 53 years. At the time of their diagnosis of vasculitis 76% of patients were working a paid job, 6% were retired, and 2% were on disability. Over the course of their disease, and with a mean follow-up of 8±6.4 years post-diagnosis, 26% of participants became permanently work disabled or had to retire early due to vasculitis. Variables that were independently associated with permanent work disability included work physicality, less supportive work environment, and symptoms such as respiratory disease, pain, and cognitive impairment. Overall, patients reported a mean productivity loss of 6.9% and income was reduced by a median of 45%. CONCLUSIONS: Due to their vasculitis, patients frequently suffer substantial limitations in work and productivity, and personal income loss.
OBJECTIVES: Work disability associated with rheumatic diseases accounts for a substantial financial burden. However, few studies have investigated disability among patients with vasculitis. The purpose of this study was to examine the impact of vasculitis on patient employment and income. METHODS:Patients enrolled in the Vasculitis Clinical Research Consortium (VCRC) Patient Contact Registry, living in the USA or Canada, and followed for >1 year post-diagnosis, participated in an online survey-based study. RESULTS: 421 patients with different systemic vasculitides completed the survey between June and December 2015. The majority of patients were female (70%) and Caucasian (90%); granulomatosis with polyangiitis (GPA) was the most common type of vasculitis (49%), and the mean age at the time of diagnosis was 53 years. At the time of their diagnosis of vasculitis 76% of patients were working a paid job, 6% were retired, and 2% were on disability. Over the course of their disease, and with a mean follow-up of 8±6.4 years post-diagnosis, 26% of participants became permanently work disabled or had to retire early due to vasculitis. Variables that were independently associated with permanent work disability included work physicality, less supportive work environment, and symptoms such as respiratory disease, pain, and cognitive impairment. Overall, patients reported a mean productivity loss of 6.9% and income was reduced by a median of 45%. CONCLUSIONS: Due to their vasculitis, patients frequently suffer substantial limitations in work and productivity, and personal income loss.
Authors: Peter C Grayson; Naomi A Amudala; Carol A McAlear; Renée L Leduc; Denise Shereff; Rachel Richesson; Liana Fraenkel; Peter A Merkel Journal: J Rheumatol Date: 2014-03-15 Impact factor: 4.666
Authors: Gustavo Citera; Hernan Maldonado Ficco; Rodolfo S Pérez Alamino; Fernando Dal Pra; Veronica Lencina; Luciana Casalla; Mariana Benegas; Oscar Rillo; Alberto Berman; Ana Lucia Barbaglia; Veronica Bellomío; Maria Haye Salinas; Ana C Alvarez; Francisco Caeiro; Josefina Marcos; Adrian Salas; Antonio Catalán Pellet; Lorena Techera; Anastasia Secco; Sergio Paira; Federico Ceccato; Zaida Bedrán; Enrique R Soriano; Josefina Marin; Gabriela Salvatierra; Maria Elena Crespo Journal: Clin Rheumatol Date: 2014-11-27 Impact factor: 2.980
Authors: Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Joachim Gutfleisch; Hartmut H Peter; Heiner H Raspe; Wolfgang L Gross Journal: Arthritis Rheum Date: 2002-06-15
Authors: Rennie L Rhee; Susan L Hogan; Caroline J Poulton; Julie Anne G McGregor; J Richard Landis; Ronald J Falk; Peter A Merkel Journal: Arthritis Rheumatol Date: 2016-07 Impact factor: 10.995
Authors: Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun Journal: Nat Rev Dis Primers Date: 2022-01-06 Impact factor: 65.038
Authors: W Benjamin Nowell; Peter A Merkel; Robert N McBurney; Kalen Young; Shilpa Venkatachalam; Dianne G Shaw; Angela Dobes; Emily Cerciello; Laura Kolaczkowski; Jeffrey R Curtis; Michael D Kappelman Journal: Patient Date: 2021-04-27 Impact factor: 3.883